XML 23 R7.htm IDEA: XBRL DOCUMENT v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT (UNAUDITED) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024 [1]   5,126      
Beginning balance at Dec. 31, 2024 $ 69,993 $ 1 [1] $ 1,366,967 [1] $ 3,601 $ (1,300,576)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 25,733   25,733 [1]    
Settlement of restricted stock (in shares) [1]   228      
Issuance of common stock pursuant to the ESPP (in shares) [1]   26      
Issuance of common stock pursuant to the 2018 ESPP (as defined below) 447   447 [1]    
Other comprehensive income (loss) (5,639)     (5,639)  
Net Income (Loss) (95,238)       (95,238)
Ending balance (in shares) at Sep. 30, 2025 [1]   5,380      
Ending balance at Sep. 30, 2025 (4,704) $ 1 [1] 1,393,147 [1] (2,038) (1,395,814)
Beginning balance (in shares) at Jun. 30, 2025 [1]   5,299      
Beginning balance at Jun. 30, 2025 58,706 $ 1 [1] 1,385,474 [1] (3,628) (1,323,141)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 7,673   7,673 [1]    
Settlement of restricted stock (in shares) [1]   81      
Other comprehensive income (loss) 1,590     1,590  
Net Income (Loss) (72,673)       (72,673)
Ending balance (in shares) at Sep. 30, 2025 [1]   5,380      
Ending balance at Sep. 30, 2025 (4,704) $ 1 [1] 1,393,147 [1] (2,038) (1,395,814)
Beginning balance (in shares) at Dec. 31, 2025 [2]   5,451      
Beginning balance at Dec. 31, 2025 (6,508) $ 1 [2] 1,399,551 [2] (1,996) (1,404,064)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 10,713   10,713 [2]    
Settlement of restricted stock (in shares) [2]   459      
Issuance of common stock pursuant to the ESPP (in shares) [2]   12      
Issuance of common stock pursuant to the 2018 ESPP (as defined below) 66   66 [2]    
Other comprehensive income (loss) 1,008     1,008  
Net Income (Loss) (28,303)       (28,303)
Ending balance (in shares) at Sep. 30, 2026 [2]   5,922      
Ending balance at Sep. 30, 2026 (23,024) $ 1 [2] 1,410,330 [2] (988) (1,432,367)
Beginning balance (in shares) at Jun. 30, 2026 [2]   5,808      
Beginning balance at Jun. 30, 2026 (16,004) $ 1 [2] 1,408,091 [2] (676) (1,423,420)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 2,239   2,239 [2]    
Settlement of restricted stock (in shares) [2]   114      
Other comprehensive income (loss) (312)     (312)  
Net Income (Loss) (8,947)       (8,947)
Ending balance (in shares) at Sep. 30, 2026 [2]   5,922      
Ending balance at Sep. 30, 2026 $ (23,024) $ 1 [2] $ 1,410,330 [2] $ (988) $ (1,432,367)
[1] The number of shares of common stock and additional paid-in capital amounts have been adjusted for the prior period presented to reflect the one-for-ten reverse stock split effected on June 5, 2026. See Note 2 -Significant Accounting Policies and Recent Accounting Standards for more information.
[2] The number of shares of common stock and additional paid-in capital amounts have been adjusted for the prior period presented to reflect the one-for-ten reverse stock split effected on June 5, 2026. See Note 2 -Significant Accounting Policies and Recent Accounting Standards for more information.